4.8 Article

Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect

Journal

NATURE GENETICS
Volume 53, Issue 2, Pages 128-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41588-020-00762-2

Keywords

-

Funding

  1. Canadian Heart Rhythm Society (George Mines Award)
  2. European Society of Cardiology
  3. Canadian Institutes of Health Research [169063]
  4. Fonds de Recherche du Quebec-Sante [135055]
  5. Philippa and Marvin Carsley Cardiology Chair
  6. British Heart Foundation Clinical Research Training Fellowship [FS/15/81/31817]
  7. Medical Research Council London Institute of Medical Sciences
  8. Medical Research Council Doctoral Training Partnership
  9. Amsterdam Cardiovascular Sciences fellowship
  10. Young Talent Program of the Dutch Heart Foundation [CVON PREDICT 2012-10]
  11. CURE-PLaN (Netherlands Heart Institute) from the Leducq Foundation
  12. Amsterdam UMC's PhD scholarship
  13. National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London
  14. Medical Research Council, UK
  15. Academy of Medical Sciences [SGL015/1006]
  16. Mason Medical Research Trust
  17. European Research Council (ERC) under the European Union [772376 - EScORIAL]
  18. German Center for Cardiovascular Research (DZHK) Rotation Grant
  19. University of Florence
  20. European Union [777204]
  21. Japan Society for the Promotion of Science [18K15410]
  22. UK Med-Bio
  23. Federation Francaise de Cardiologie
  24. Ligue contre la cardiomyopathie
  25. CONNY-MAEVA charitable foundation
  26. GenMed LABEX
  27. Dutch Heart Foundation Netherlands Cardiovascular Research Initiative (CVON) [PREDICT2 2018-30, eDETECT 2015-12, DOSIS 2014-40, DOLPHIN-GENESIS 2017-10]
  28. Jacob J. Wolfe Distinguished Medical Research Chair
  29. Edith Schulich Vinet Research Chair in Human Genetics
  30. Martha G. Blackburn Chair in Cardiovascular Research
  31. Canadian Institutes of Health Research
  32. Heart and Stroke Foundation of Canada [G-18-0022147]
  33. Montreal Heart Institute Foundation
  34. UK Research and Innovation Rutherford Fellowship
  35. UCL Hospitals NIHR Biomedical Research Centre
  36. Dutch Heart Foundation [2016T096]
  37. Netherlands Organization for Health Research and Development (ZonMw)
  38. Department of Health, UK [HICF-R6-373]
  39. Medical Research Council
  40. NIHR Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London
  41. British Heart Foundation Program [RG/19/6/34387]
  42. Foundation Volksbond Rotterdam
  43. Monat foundation
  44. J. C. Edwards Foundation
  45. Canada Research Chair Program
  46. DZHK
  47. German Ministry of Education and Research (CaRNAtion)
  48. Informatics for Life (Klaus Tschira Foundation)
  49. European Union
  50. Else Kroner Fresenius Foundation
  51. PROMEX charitable foundation
  52. Wellcome Trust [090532/Z/09/Z, 107469/Z/15/Z]
  53. BHF Centre of Research Excellence, Oxford [RE/13/1/30181]
  54. NIHR Oxford Biomedical Research Centre
  55. National Heart, Lung and Blood Institute [U01HL117006-01A1]
  56. Edmond J. Safra Foundation
  57. Lily Safra, an NIHR Senior Investigator Award
  58. UK Dementia Research Institute
  59. British Heart Foundation [SP/17/11/32885, RE/18/4/34215]
  60. Medical Research Council (UK)
  61. NIHR Royal Brompton Cardiovascular Biomedical Research Unit
  62. NIHR Imperial College Biomedical Research Centre
  63. Netherlands Organization for Scientific Research [016.150.610]
  64. Leducq Foundation [17CVD02]
  65. Common Fund of the Office of the Director of the National Institutes of Health
  66. National Cancer Institute (NCI)
  67. National Human Genome Research Institute (NHGRI)
  68. National Heart, Lung and Blood Institute (NHLBI)
  69. National Institute on Drug Abuse (NIDA)
  70. National Institute of Mental Health (NIMH)
  71. National Institute of Neorological Disorders and Stroke (NINDS)
  72. European Union's Horizon 2020 research and innovation program under the ERA-NET Co-fund action [680969]
  73. Dutch Heart Foundation Netherlands Cardiovascular Research Initiative (PRIME)
  74. MRC [MC_U120085815, MC_UP_1102/20, MC_UP_1102/19, MR/S003754/1] Funding Source: UKRI
  75. Grants-in-Aid for Scientific Research [18K15410] Funding Source: KAKEN

Ask authors/readers for more resources

The study found a strong genetic correlation between hypertrophic and dilated cardiomyopathies and left ventricular traits, with opposing genetic effects in the two cardiomyopathies. The research also supported a causal association between increased left ventricular contractility and hypertrophic cardiomyopathy risk.
The heart muscle diseases hypertrophic (HCM) and dilated (DCM) cardiomyopathies are leading causes of sudden death and heart failure in young, otherwise healthy, individuals. We conducted genome-wide association studies and multi-trait analyses in HCM (1,733 cases), DCM (5,521 cases) and nine left ventricular (LV) traits (19,260 UK Biobank participants with structurally normal hearts). We identified 16 loci associated with HCM, 13 with DCM and 23 with LV traits. We show strong genetic correlations between LV traits and cardiomy-opathies, with opposing effects in HCM and DCM. Two-sample Mendelian randomization supports a causal association linking increased LV contractility with HCM risk. A polygenic risk score explains a significant portion of phenotypic variability in carriers of HCM-causing rare variants. Our findings thus provide evidence that polygenic risk score may account for variability in Mendelian diseases. More broadly, we provide insights into how genetic pathways may lead to distinct disorders through opposing genetic effects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available